Genotyping of Human Papillomavirus

Size: px
Start display at page:

Download "Genotyping of Human Papillomavirus"

Transcription

1 VisinArray Arrays fr DNA analysis Gentyping f Human Papillmavirus mplete C r u Y frm n i t u l S ctin a r t x E DNA sis! y l a n A t Simultaneus Detectin f 41 HPV Types High Sensitivity Easy t Handle

2 Imprtance f HPV Testing The human papillmavirus (HPV) has been cnclusively identified as the majr risk factr fr cervical cancer. It is the third mst cmmn cancer in wmen wrldwide, with an estimated number f 530,000 new cases and 280,000 deaths each year. Over the last years the relevance f HPV in the histry f rpharyngeal cancers has becme mre and mre imprtant which is indicated by a dramatically risen number f cancers f the ral cavity and pharynx linked t HPV. Cervical Cancer Prgressin Initial HPV infectin requires virin integratin int the basal epithelial cells. Whereas mst HPV infectins are transient and are cleared by the immune system, infectin with HPV high risk types may lead t cancer when infectin persists. Expsure Transient Infectin Persistant Infectin Infectin Prgressin Invasin Nrmal Cervix Clearance Prductive Infectin Regressin Precursr Lesin Cancer Cytlgy? Cytlgy? HPV Gentype? Cytlgy? HPV Gentype? Cytlgy? HPV Gentype? Duratin mnths 24 mnths 7-15 years VisinArray HPV Chip Fast and Reliable Gentyping The VisinArray HPV Chip 1.0 is intended t be used with the VisinArray Analysis Package fr the qualitative detectin and gentyping f PCR amplificates f 41 clinically relevant HPV gentypes High Risk HPV Types detected by the VisinArray HPV Chip a 68b IS39 MM Prbably High Risk HPV Types detected by the VisinArray HPV Chip a 68a b MM4 82 IS39 68b (IS39) 82 (MM4) Lw Risk HPV Types detected by the VisinArray HPV Chip High Risk Prbably High Risk Lw Risk Guide Dts/Psitive Cntrl (CP8304) 83 (MM7) 84 (MM8) References: Bumba LM, et al. (2014) BMC Public Health 14: 1320 Clmb N, et al. (2012) Ann Oncl 23 Suppl 7: vii27-32 Crw JM, et al. (2012) Nature 488: S2-S3 IARC (2012) Bilgical Agents. IARC Mngr Eval Carcing Risks Hum, 100B: Pljak M, et al. (2016) J Clin Virl 76 Suppl 1: S3-S13

3 1. Sample Cllectin Fr the detectin f HPV gentypes with the VisinArray HPV system the fllwing raw material can be used fr DNA extractin: Frmalin-fixed, paraffin-embedded (FFPE) tissue samples Cervical swab/brush specimen Liquid based cytlgy specimen (ThinPrep ) 2. Detectin & Differentiatin f 41 HPV Types Step 1: Amplificatin and Labeling in a PCR Bitinylated primers are used t amplify and label different sectins f the L1 regin f the HPV genme. The human HLA-DQA1 gene is als amplified and serves as a PCR psitive cntrl and as a genmic cntrl. Step 2: Hybridizatin n the Glass Chip After amplificatin, the bitinylated sequences hybridize t cmplementary DNA capture sequences n the glass chip. Step 3: Detectin and Visualizatin Specifically bund and bitinylated sequences are visualized by secndary marking with a streptavidinperxidase cnjugate and a staining with tetramethylbenzidine. After clr develpment, evaluatin is perfrmed using the VisinArray Analyzer Sftware.

4 3. Wrkflw Schedule This is a cndensed prtcl fr the VisinArray methd and shuld nt replace the instructin fr use! 0 Min. PCR Fr the PCR the VisinArray Primer Kit is used The master mix is prepared by using the dntp/dutp Slutin, HPV Primer Mix, VisinArray PreCise Taq Plymerase, VisinArray Uracil-DNA Glycsylase and the crrespnding reactin buffers Alternatively: The VisinArray HPV PreCise Master Mix can be used DNA sample is added t the master mix Hybridizatin PCR prduct and Hybridizatin Slutin are mixed well Mix is applied nt the VisinArray Chip 30 Min. Duratin: 30 min Stringency Wash Unbund DNA fragments are remved using 1x Wash Buffer Drying f VisinArray Chip by centrifugatin Duratin: 2 min Detectin Marking f bitinylated sequences using the Detectin Slutin Visualizatin is perfrmed by applying the Blue Spt Slutin 50 Min. Duratin: 17 min Wash Remving f the Blue Spt Slutin by washing with 1x Wash Buffer Drying f VisinArray Chip by centrifugatin Duratin: 2 min Analysis 60 Min. Chips are scanned with VisinArray Scanner 8100 Autmated analysis is perfrmed by using the VisinArray Analyzer Sftware Duratin: 10 min Quick & easy 1 hur prtcl Autmated user-friendly evaluatin within a few minutes

5 HPV Tests in Cmparisn Assay Gentyping C-infectin N. f CE-IVD HPV Types (cpies/reactin) Anyplex TM II HPV28 Detectin Cervista HPV HR CLART HPV (3, 4) HPV HPV cpies/ml digene HC2 HPV DNA Test INNO-LiPA HPV Gentyping Extra II cbas HPV Test VisinArray * Sensitivity data are accrding t the respective instructin fr use VisinArray At a Glance Simultaneus gentyping f 41 different HPV types all certified fr in vitr diagnstic use All capture sequences and psitive cntrls are set up n the VisinArray Chip as duplicates High sensitivity and specificity Quick & easy 1 hur prtcl Autmated evaluatin using the VisinArray Analyzer Sftware simple visualizatin & quick analysis in just a few minutes Sensitivity*

6 VisinArray Arrays fr DNA analysis VisinArray HPV Chips Prd. N. Prduct Tests VA VisinArray HPV Chip Incl. 10 pieces VA VisinArray HPV Chip Incl. 5x 10 pieces VA VisinArray HPV High Risk Chip Incl. 10 pieces VA VisinArray HPV High Risk Chip Incl. 5x 10 pieces VisinArray DNA Extractin, PCR, and Detectin Prd. N. Prduct Tests VI VisinArray FFPE DNA Extractin Kit 50 Incl. Paraffin Disslver; Tissue Lysis Buffer; Decrsslink Buffer; DNA Wash Buffer; Prteinase K; Prteinase K Buffer; Elutin Buffer; Clumns; Cllectin Tubes VI VisinArray Cytlgy DNA Extractin Kit 50 Incl. Pre-Lysis Buffer; Cell Lysis Buffer; DNA Wash Buffer; Prteinase K; Prteinase K Buffer; Elutin Buffer; Clumns; Cllectin Tubes Prd. N. Prduct Tests VP VisinArray HPV Primer Kit 50 Incl. HPV Primer Mix; dntp/dutp Slutin VE VisinArray PreCise Taq DNA Plymerase 100 Incl. VisinArray PreCise Taq DNA Plymerase, Reactin Buffer, 10x; PreCise MgCl 2, 25 mm VE VisinArray Uracil-DNA Glycsylase 100 Incl. VisinArray Uracil- DNA Glycsylase (UDG), UDG Reactin Buffer, 10x ES VisinArray HPV PreCise Master Mix 50 Prd. N. Prduct Tests VK VisinArray Detectin Kit 50 Incl. Hybridizatin Slutin, 1 ml; Detectin Slutin, 5 ml; Blue Spt Slutin, 5 ml; 100x Wash Buffer, 250 ml E Mini Slide Centrifuge VisinArray Analysis Package Prd. N. E Prduct VisinArray Analysis Package Incl. Scanner 8100; Slide Hlder; Hand Scanner; PC with preinstalled VisinArray Analyzer Sftware; USB-Hub; External Hard Drive; Cmputer Muse nly available in certain cuntries. All ther cuntries research use nly! Please cntact yur lcal dealer fr mre infrmatin. M Manufactured by: 42 life sciences GmbH & C. KG Fischkai Bremerhaven Germany Distributed by: ZytVisin GmbH Fischkai Bremerhaven Germany inf@zytvisin.cm VisinArray is a trademark f 42 life sciences GmbH & C. KG

HIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory)

HIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory) HIV Diagnstic Tests HIV Testing Algrithm at SydPath (Natinal Reference Labratry) HIV1/2 Ab/Ag Cmbi is Architect HIV- 1 Ab/Ag EIA is Genscreen Sandwich EIA 4 th Generatin HIV Ab/Ag Chemiluminescene Micr

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

ABIOpure TM Total RNA (version 2.0)

ABIOpure TM Total RNA (version 2.0) ABIOpure TM Ttal RNA (versin 2.0) Bld Extractin Handbk Cat N: M541RP50-B FOR RESEARCH USE ONLY Table f Cntents Cntents Page Kit Cmpnents 3 Precautins 3 Stability & Strage 4 General Descriptin 4 Limitatins

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

For Research Use Only Ver

For Research Use Only Ver INSTRUCTION MANUAL Quick-cfRNA Serum & Plasma Kit Catalg N. R1059 Highlights High-quality cell-free RNA is easily and rbustly purified frm up t 3 ml f plasma, serum, r ther bilgical fluids. Purified cell-free

More information

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION PROTOCOL SOD2 Prtein Quantity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS746 Rev.0 DESCRIPTION SOD2 Prtein Quantity Micrplate Assay Kit Sufficient materials are prvided fr

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study PONS Study Synpsis Title f the Study Subtype-Stratified Fllw-up Care Study f Breast Cancer Patients with Cmbined In Vitr and In Viv Diagnstics Plus Early Target-Oriented Interventin Gals Imprve and individualize

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

NHAIS SIS Communication

NHAIS SIS Communication T: All NHAIS Key Users/Screening Managers Frm: Catherine Rberts SIS Request: T/14528 HSCIC Change Number: 15846 Date: 24/03/2015 Page 1 f 5 Impacted Applicatins: SD screen, Lab Links, MM screen, AJ-CD

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Data Fusion for Predicting Breast Cancer Survival

Data Fusion for Predicting Breast Cancer Survival Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current

More information

Section IA-Introduction

Section IA-Introduction Immunizatin Prgrams and Vaccine Preventable Diseases Service 655 West 12th Avenue Vancuver, BC V5Z 4R4 Tel 604.707.2548 Fax 604.707.2515 www.bccdc.ca Date: May 15, 2017 Administrative Circular: 2017:07

More information

Reducing Cervical Cancer in the Sololá Department of Guatemala

Reducing Cervical Cancer in the Sololá Department of Guatemala 1 Reducing Cervical Cancer in the Sllá Department f Guatemala Intrductin The Bates Fundatin is seeking t fund a prpsal fr a cmprehensive cervical cancer demnstratin prject in Guatemala s Sllá Department.

More information

CONTENTS. 1. NEO-SENSITABS TM a. Susceptibility Testing b. Antifungal c. Veterinary 2. ACCESSORIES. 3. DIATABS TM Identification of Bacteria and Fungi

CONTENTS. 1. NEO-SENSITABS TM a. Susceptibility Testing b. Antifungal c. Veterinary 2. ACCESSORIES. 3. DIATABS TM Identification of Bacteria and Fungi 2017 PRODUCT LIST CONTENTS 1. NEO-SENSITABS TM a. Susceptibility Testing b. Antifungal c. Veterinary 2. ACCESSORIES 3. DIATABS TM Identificatin f Bacteria and Fungi 4. REAGENTS 5. KITS TM Fr Detectin f

More information

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer.

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer. Your Power for Health Laboratory Information hr-hpv DNA-Chip Know for sure! PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer. PapilloCheck and

More information

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

FTD RESEARCH: The Value of Studies and Opportunities for Involvement FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

Volume Measurement at CT

Volume Measurement at CT Vlume Measurement at CT Staging and Assessment f Respnse with Quantitative CT Lawrence Schwartz, MD Department f Radilgy Clumbia University Cllege f Physicians and Surgens LSCHWARTZ@COLUMBIA.EDU Recmmendatins

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Health Science Ch. 16 Cancer Lecture Outline

Health Science Ch. 16 Cancer Lecture Outline Cancer Leading cause f disease-related death amng peple under age 75 Secnd leading cause f death Evidence supprts that mst cancers culd be prevented by simple lifestyle changes Tbacc is respnsible fr abut

More information

LYME DISEASE (taken from 6/20/13)

LYME DISEASE (taken from   6/20/13) LYME DISEASE (taken frm www.lymemd.rg 6/20/13) PREVENTING LYME DISEASE Understand the risks The risk f Lyme disease is year rund. Highest risk late spring t early summer. Learn t enjy the utdrs SAFELY.

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent Prtcl Preparatin Prtcl fr the Nn-Targeted Vev MicrMarker Cntrast Agent System Cmpatibility: This guide cntains instructins and suggestins fr wrk n the Vev2100, VevLAZR, Vev 3100 systems and transducers

More information

INFERTILITY DIAGNOSIS

INFERTILITY DIAGNOSIS INFERTILITY Infertility is the inability t cnceive after 12 mnths f unprtected intercurse. There are multiple causes f infertility and a systematic way t evaluate the cnditin. Let s lk at sme f the causes.

More information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL Cncussin awareness has increased significantly in recent years. The Natinal Cllegiate Athletic Assciatin (NCAA), Natinal Athletic Trainers Assciatin

More information

Cnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

Be sure! Your Power for Health. PelvoCheck CT/NG Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections

Be sure! Your Power for Health. PelvoCheck CT/NG Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections Your Power for Health Laboratory Information CT/NG DNA-Chip Be sure! Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections is part of the ocheck product line from Greiner

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

SQA-VISION VALIDATION REPORT

SQA-VISION VALIDATION REPORT Objective SQA-VISION VALIDATION REPORT T test the new cnvenience features f the SQA-Visin vs. the SQA-V and manual semen assessment: Swim-up Density Gradient Lngevity Vitality Mrphlgy Cunter Scanning Debris/Rund

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY

SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY Sme 50% f cancers that affect wmen are lcated in the breast r in the genital rgans. Gynaeclgical

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Institutions. Residential care homes in the UK, refugee camps in some parts of the world.

Institutions. Residential care homes in the UK, refugee camps in some parts of the world. Scabies Scabies is an itchy rash caused by the parasitic mite Sarcptes scabiei. Scabies has caused pruritic infestatin in humans fr ver 2,500 years. The female scabies mite is abut 0.4 mm lng, and the

More information

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1

International Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1 Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,

More information

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 2009: DrillSafe Update David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 Update CDC.Gv USA Pandemic H1N1 Summary Pints Virus cntinues t spread with nearly all WHO

More information

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided

More information

ACRIN 6666 Screening Breast US Follow-up Assessment Form

ACRIN 6666 Screening Breast US Follow-up Assessment Form Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related

More information

Directory of Laboratory Services

Directory of Laboratory Services Directry f Labratry Services Interpace Diagnstics Crpratin www.interpacediagnstics.cm TEL: 800.495.9885 CO-SOP-1007 Directry f Labratry Services Table f Cntents List f Testing Services... 3 Acceptable

More information

EMEA DICOMBurner solution EMEA DICOMBurner solution

EMEA DICOMBurner solution EMEA DICOMBurner solution The mdern PACS (Picture Archiving and Cmmunicatin System) digital revlutin appears t ffer significant savings in terms f variable csts. Nevertheless, the filmless technlgy is a real advantage if there

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

DHMO Provider Choice Product Exit, 2-50 and 51+

DHMO Provider Choice Product Exit, 2-50 and 51+ Date: April 27, 2018 Market: Dental, 2-50 and 51+ DHMO Prvider Chice Prduct Exit, 2-50 and 51+ Maryland and Virginia Only Beginning with July 2018 renewals, DHMO Prvider Chice (PC) plans will be discntinued

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Before Your Visit: Mohs Skin Cancer Surgery

Before Your Visit: Mohs Skin Cancer Surgery Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media

Triumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media Triumeq (abacavir, dlutegravir and lamivudine) Prduct Backgrunder fr US Media What is Triumeq and wh is Triumeq fr? Triumeq (abacavir 600mg, dlutegravir 50mg and lamivudine 300mg) is the first dlutegravir-based

More information

Humanities and Social Sciences Division. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses

Humanities and Social Sciences Division. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: SIGN 108 Fingerspelling Humanities and Scial Sciences Divisin Sign

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg

INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injection, for Subcutaneous Use Single-Dose Prefilled Syringe 150 mg INSTRUCTIONS FOR USE ZINBRYTA (zin-bry-tuh) (daclizumab) Injectin, fr Subcutaneus Use Single-Dse Prefilled Syringe 150 mg Read this Instructins fr Use befre yu start using ZINBRYTA and each time yu get

More information

President Chirac understood that fighting disease is not just health systems and hospitals, it is about people. We must place people at the centre.

President Chirac understood that fighting disease is not just health systems and hospitals, it is about people. We must place people at the centre. Michel Sidibé Executive Directr, UNAIDS Speech Opening Ceremny 2016 Wrld Cancer Cngress 31 st Octber 2016, Paris, France Cngratulatins and grateful thanks t the rganizers - Unin fr Internatinal Cancer

More information

MEDICATION GUIDE. (fingolimod) capsules

MEDICATION GUIDE. (fingolimod) capsules MEDICATION GUIDE GILENYA (je-len-yah) (finglimd) capsules Read this Medicatin Guide befre yu start using GILENYA and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take the

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care. Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,

More information

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth. DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

Chapter 5 Anxiety Disorders

Chapter 5 Anxiety Disorders Test Review 2 Chapter 5 Anxiety Disrders Mst cmmn and effective frm f treatment = Expsure Anxiety Disrders Mst cmmn psychiatric disrders Phbias mst cmmn f the anxiety disrders Often Cmrbid with Majr Depressin

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium

Package leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

Standard Operating Procedures for Quantitative HIV-1 viral load testing using GeneXpert technology. June 2015

Standard Operating Procedures for Quantitative HIV-1 viral load testing using GeneXpert technology. June 2015 Standard Operating Prcedures fr Quantitative HIV-1 viral lad testing using GeneXpert technlgy June 2015 1 Versin 0 Effective date: 10 June 2014 Table f Cntents I. Title f Prcedure... 3 II. Test Summary...

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

2. How are screening and diagnostic mammograms different?

2. How are screening and diagnostic mammograms different? Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram

More information

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

Extended G/L Segment Codes

Extended G/L Segment Codes Extended G/L Segment Cdes Cpy Segment Cdes t ther Sage 300 cmpanies Extended G/L Segment Cdes Extended G/L Segment Cdes is an enhanced replacement fr the Sage G/L Segment Cdes screen. It lets yu cpy segment

More information

The Cell Cycle & Cellular Division

The Cell Cycle & Cellular Division The Cell Cycle & Cellular Divisin Name: Perid: Date: I. Cell Divisin: All are derived frm preexisting cells (Cell Thery) is the prcess by which cells prduce new cells Cells grw in number, NOT in Smaller

More information

Protocol Abstract and Schema

Protocol Abstract and Schema NCI Prtcl #: PBTC-042 Lcal Prtcl #: PBTC-042 Prtcl Abstract and Schema PBTC-042: Phase I study f CDK 4-6 inhibitr PD-0332991 (palbciclib; IBRANCE) in children with recurrent, prgressive r refractry central

More information

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE

2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE 2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizatins, Clinical Cascade Breakut Sessin TB/HIV EXERCISE Created by the ICPI TB/HIV Wrkstream Abut this Handut

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

BSUG Database User Update Document June 15 th 2015

BSUG Database User Update Document June 15 th 2015 1 Welcme t the BSUG Online Database BSUG Audit Database is an nline database tl prvided by the BSUG t gather data relating t this subspecialty fr the purpses f prviding BSUG members with statistical reprts

More information

HPV VACCINATION IN SANDYFORD SERVICES

HPV VACCINATION IN SANDYFORD SERVICES HPV VACCINATION IN SANDYFORD SERVICES 1. General infrmatin n HPV Vaccinatin 2. HPV vaccinatin in females 3. Yung Wmen Only 4. HPV vaccinatin in MSM 1. General infrmatin General Infrmatin fr clinicians

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use

PATIENT INFORMATION. (methotrexate) injection, for subcutaneous use What is Rasuv? PATIENT INFORMATION RASUVO (ruh-soo-vh) (methtrexate) injectin, fr subcutaneus use Rasuv is a single-dse manually-triggered aut-injectr cntaining a prescriptin medicine, methtrexate. Methtrexate

More information

2. What is SO 2? 3. The World Health Organization states that air pollution.

2. What is SO 2? 3. The World Health Organization states that air pollution. Air Quality Statins Statin 1: Study the website, Our Wrld Data, and answer the fllwing questins. 1. Accrding t this website, what is the definitin f air pllutin? 2. What is SO 2? 3. The Wrld Health Organizatin

More information

INCLUDED. Oral Care Control Device Interchangeable Mouth Tray Power Supply Power Cable Storage Case Silicone Cleaning Cover (Do Not Discard)

INCLUDED. Oral Care Control Device Interchangeable Mouth Tray Power Supply Power Cable Storage Case Silicone Cleaning Cover (Do Not Discard) INCLUDED Oral Care Cntrl Device Interchangeable Muth Tray Pwer Supply Pwer Cable Strage Case Silicne Cleaning Cver (D Nt Discard) Interchangeable Muth Tray Pwer Supply Pwer Cable Oral Care Cntrl Device

More information

MEDICATION GUIDE. (Interferon alfa-2b)

MEDICATION GUIDE. (Interferon alfa-2b) MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

How to Get Set Up and Running with NDepend

How to Get Set Up and Running with NDepend Hw t Get Set Up and Running with NDepend Whether yu have purchased r dwnladed the trial f NDepend, we thank yu fr yur invlvement and interest in ur prduct. Here we have cmpiled a quick "Getting Started"

More information

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality

Refining Blood Collection Techniques to Improve Animal Welfare and Sample Quality Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,

More information

EAST VALLEY DERMATOLOGY CENTER

EAST VALLEY DERMATOLOGY CENTER EAST VALLEY DERMATOLOGY CENTER Adult and Pediatric Dermatlgy VALLEY SKIN CANCER SURGERY PATIENT INFORMATION RECORD Please Use Black Ink Only Patient Infrmatin Patient s Name Last First Middle Initial Address

More information

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution

Instructions for Use INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) Powder for Solution Instructins fr Use INTRON A (In-trn-aye) (Interfern alfa-2b, recmbinant) Pwder fr Slutin Be sure that yu read, understand, and fllw these instructins befre injecting INTRON A. Yur healthcare prvider shuld

More information

REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES

REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES A Registered Reprt is a frm f empirical article ffered at Nature Human Behaviur in which the methds and prpsed analyses are pre-registered and reviewed

More information